Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 48Rectal Neoplasms 42Pancreatic Neoplasms 29Esophageal Squamous Cell Carcinoma 19Adenocarcinoma Of Esophagus 15Stomach Neoplasms 14Colorectal Neoplasms 8Anus Neoplasms 8Carcinoma, Hepatocellular 7Neoplasms 6Neoplasm Metastasis 6Cholangiocarcinoma 5Locally Advanced Rectal Cancer 4Uterine Cervical Neoplasms 3Sarcoma 3Melanoma 3Anal Canal Carcinoma 3Adenocarcinoma 3Vulvar Neoplasms 2Vaginal Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Esophageal Diseases 2Endometrial Neoplasms 2Diabetes Mellitus, Insulin-Dependent, 12 2Colonic Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Non-Small-Cell Lung 2

Interventions

pembrolizumab 44Fluorouracil 16Cisplatin 15Oxaliplatin 13Capecitabine 11Paclitaxel 10lenvatinib 8Leucovorin 8Irinotecan 6Docetaxel 6trifluridine tipiracil drug combination 3regorafenib 3Saline Solution 3Levoleucovorin 3Gemcitabine 3Bevacizumab 3patritumab deruxtecan 2Trastuzumab 2S 1 (combination) 2Radiotherapy 2Cetuximab 2Carboplatin 2zanidatamab 1vicriviroc 1tremelimumab 1tislelizumab 1tipiracil 1spartalizumab 1sinoporphyrin sodium 1ribociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body × Radiation × Gastrointestinal × Clear all
NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Ludwig Institute for Cancer Research

Phase 1/2 Completed
73 enrolled 18 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡